Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Curosurf Injection Supplier in India. Curosurf Poractant Alfa Injection Supplier wholesale exporter, trader and supplier in India
Most trusted Curosurf 120mg Injection Supplier in India. Order in bulk quantity Curosurf Injection at wholesale rate from India.
Curosurf Poractant Alfa Injection is a leading drug used in the treatment of Respiratory Distress Syndrome (RDS) in premature infants, especially in neonatal intensive care units. Reduction of surface tension in the lungs is the main mechanism of the drug by which the alveoli remain open, and oxygenation is rapidly improved. The injection comes in a concentration of 80 mg/ml, and the dosage forms of 1.5 ml and 3 ml vials allow for exact and versatile dosing according to the infant’s clinical needs.
Welox Pharma offers original Curosurf Injection which is appropriately quality assured with a worldwide supply network. The product packaging is safe and secure with the presentation of 1.5 ml and 3 ml, thereby guaranteeing proper handling, storage, and transportation under necessary conditions. At competitive prices and giving the orders on time, it is a perfect selection for hospitals, clinics, and pharmaceutical distributors which are in need of reliable neonatal care products.
Curosurf Injection is used for respiratory distress syndrome (immature lungs in preterm baby). It is effective in babies who have difficulty breathing due to a lack of enough lubricants in their lungs.
Curosurf Injection is given under the supervision of a healthcare professional in the hospital setting. Your doctor will decide how much you need to improve your symptoms Infants are continuously monitored to avoid any medical emergency.
Pneumothorax (accumulation of air or gas in the chest or pleural space), brain hemorrhage, chronic lung disease, decreased oxygen level in the blood, and infection are some serious side effects of this medicine. Your doctor will be the best person to decide how to overcome the side effects.
Respiratory distress syndrome occurs when there is not enough surfactant in the lungs. Surfactant is a liquid made by the lungs that keeps the airways (alveoli) open. Curosurf Injection provides a fatty coating on the lung surface of the baby, prevents collapse of the lungs, and sticking together while breathing in and out. This helps the airways in your lungs stay open and also relax the muscles of these airways. As a result, it is easier for air to get in and out of the lungs of the baby. It is given as an injection by a doctor or nurse. Follow your doctors instructions carefully.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youre worried about them
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Curosurf Injection is the surfactant given to premature babies to protect their lungs. The surfactant is a fatty substance that coats the inside or lining of the air sacs in the lungs. This coating prevents the air sacs from collapsing and sticking together when air leaves the lungs. The surfactant is produced by babies only after the 8th month of pregnancy.
Beside this well also export in other countries